NAMS
NewAmsterdam Pharma Company NV

470
Mkt Cap
$3.68B
Volume
995,475.00
52W High
$42.00
52W Low
$14.06
PE Ratio
-18.78
NAMS Fundamentals
Price
$32.81
Prev Close
$32.01
Open
$32.61
50D MA
$32.38
Beta
1.09
Avg. Volume
936,653.55
EPS (Annual)
-$1.72
P/B
5.49
Rev/Employee
$225,030.00
$3,516.96
Loading...
Loading...
News
all
press releases
JPMorgan Chase & Co. Trims Stock Position in NewAmsterdam Pharma Company N.V. $NAMS
JPMorgan Chase & Co. cut its holdings in shares of NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Free Report) by 10.7% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,302,498 shares of the company's stock after sell...
MarketBeat·11d ago
News Placeholder
More News
News Placeholder
NewAmsterdam Pharma (NASDAQ:NAMS) Now Covered by Truist Financial
Truist Financial assumed coverage on NewAmsterdam Pharma in a research report on Wednesday. They set a "buy" rating and a $57.00 price target on the stock...
MarketBeat·14d ago
News Placeholder
NewAmsterdam Pharma Company N.V. $NAMS is Decheng Capital LLC's 5th Largest Position
Decheng Capital LLC trimmed its position in NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Free Report) by 14.7% in the 3rd quarter, according to the company in its most recent Form 13F filing with...
MarketBeat·17d ago
News Placeholder
ArrowMark Colorado Holdings LLC Has $8.85 Million Holdings in NewAmsterdam Pharma Company N.V. $NAMS
ArrowMark Colorado Holdings LLC reduced its position in shares of NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Free Report) by 13.3% in the 3rd quarter, according to the company in its most recent...
MarketBeat·17d ago
News Placeholder
NewAmsterdam Pharma (NASDAQ:NAMS) Director Sells $1,357,309.98 in Stock
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report) Director Louis Lange sold 44,619 shares of the business's stock in a transaction on Wednesday, March 11th. The stock was sold at an...
MarketBeat·20d ago
News Placeholder
NewAmsterdam Pharma Company N.V. $NAMS Shares Bought by American Century Companies Inc.
American Century Companies Inc. lifted its position in shares of NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Free Report) by 17.1% in the 3rd quarter, according to its most recent disclosure with...
MarketBeat·22d ago
News Placeholder
Louis Lange Sells 28,186 Shares of NewAmsterdam Pharma (NASDAQ:NAMS) Stock
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report) Director Louis Lange sold 28,186 shares of the stock in a transaction dated Friday, March 6th. The shares were sold at an average...
MarketBeat·22d ago
News Placeholder
Johannes Jacob Piete Kastelein Sells 101,409 Shares of NewAmsterdam Pharma (NASDAQ:NAMS) Stock
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report) insider Johannes Jacob Piete Kastelein sold 101,409 shares of the business's stock in a transaction that occurred on Monday, March...
MarketBeat·23d ago
News Placeholder
Insider Selling: NewAmsterdam Pharma (NASDAQ:NAMS) Insider Sells 94,124 Shares of Stock
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report) insider Johannes Jacob Piete Kastelein sold 94,124 shares of the company's stock in a transaction on Friday, March 6th. The shares...
MarketBeat·23d ago
News Placeholder
Insider Selling: NewAmsterdam Pharma (NASDAQ:NAMS) Insider Sells $3,165,350.10 in Stock
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report) insider Johannes Jacob Piete Kastelein sold 104,467 shares of the firm's stock in a transaction on Thursday, March 5th. The stock was...
MarketBeat·23d ago
<
1
2
...
>

Latest NAMS News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.